Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 November 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 216 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 11 results:
Author Title Type [ Year(Asc)]
Filters: Author is Croft, P.  [Clear All Filters]
2020
Y. Chen, Hayward, R., Chew-Graham, C. A., Hubbard, R., Croft, P., Sims, K., and Jordan, K. P., “Prognostic value of first-recorded breathlessness for future chronic respiratory and heart disease a cohort study using a UK national primary care database”, Br J Gen Pract, 2020.
2014
S. Weich, Pearce, H. L., Croft, P., Singh, S., Crome, I., Bashford, J., and Frisher, M., “Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study”, Bmj, vol. 348, p. g1996, 2014.
2013
K. P. Jordan, Hayward, R. A., Blagojevic-Bucknall, M., and Croft, P., “Incidence of prostate, breast, lung and colorectal cancer following new consultation for musculoskeletal pain: a cohort study among UK primary care patients”, Int J Cancer, vol. 133, pp. 713-20, 2013.
M. Frisher, Martino, O. I., Bashford, J., Crome, I., and Croft, P., “Incidence of psychoses among drug dependent patients in primary care with no psychiatric history: a retrospective observational matched-cohort study”, The European Journal of Psychiatry, vol. 27, pp. 240-7, 2013.
2010
K. P. Jordan and Croft, P., “Mortality and cancer in patients with new musculoskeletal episodes: a cohort study”, Br J Gen Pract, vol. 60, pp. e105-11, 2010.
2009
M. Frisher, Crome, I., Martino, O., and Croft, P., “Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005”, Schizophr Res, vol. 113, pp. 123-8, 2009.
M. Frisher, Martino, O., Crome, I., and Croft, P., “Trends in drug misuse recorded in primary care in the UK from 1998 to 2005”, J Public Health (Oxf), vol. 31, pp. 69-73, 2009.
2007
K. Jordan, Clarke, A. M., Symmons, D. P., Fleming, D., Porcheret, M., Kadam, U. T., and Croft, P., “Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases”, Br J Gen Pract, vol. 57, pp. 7-14, 2007.
2005
M. Frisher, Crome, I., Macleod, J., Millson, D., and Croft, P., “Substance misuse and psychiatric illness: prospective observational study using the general practice research database”, J Epidemiol Community Health, vol. 59, pp. 847-50, 2005.
2004
M. Frisher, Collins, J., Millson, D., Crome, I., and Croft, P., “Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales”, J Epidemiol Community Health, vol. 58, pp. 1036-41, 2004.
2000
D. Millson, Frischer, M., Croft, P., and Goadsby, P. J., “Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?”, Cephalalgia, vol. 20, pp. 732-7, 2000.
[Page last reviewed 6 November 2020]